AI helps doctors spot cancerous polyps during colonoscopy
NCT ID NCT06791395
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an artificial intelligence (AI) tool that helps doctors diagnose colorectal polyps during a colonoscopy. The AI analyzes images from a special high-magnification endoscope to predict whether a polyp is cancerous or not. The goal is to improve accuracy and reduce unnecessary biopsies. The study involved 570 patients and was completed at multiple hospitals.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Computer-aided diagnosis (CADx) support tool
- What this could lead to
- If successful, this AI tool could help doctors accurately diagnose colorectal polyps during colonoscopy, reducing the need for biopsies and lowering costs.
- What could go wrong
- This is a completed study, but the AI may not work as well in all patients or settings. It is a diagnostic aid, not a treatment, and errors could still occur.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
570 people
The number who actually took part.
- Started
-
Feb 2025
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with one or more colorectal lesions detected during endocytoscopy will be included in the study. The rest of the inclusion and exclusion criteria are as described.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients who have at least one colorectal lesion detected during endocytoscopy * Consent obtained for the study Exclusion Criteria: * lesions lacking high-quality images; * Inflammatory bowel disease, familial adenomatous polyposis and other special diseases; * Submucosal tumors; * Pathological diagnosis of inflammatory polyps, Peutz-Jeghers polyps, juvenile polyps, lymphoma and other special pathological types.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colorectal neoplasms are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Meihekou Central Hospital
Meihekou, Jilin, 135000, China
-
Shandong Second Provincial General Hospital
Jinan, Shandong, 250000, China
-
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI could classify colon polyps on the spot, skipping the lab
- Can a computer model read MRI scans to predict which liver cancer patients will relapse?
- Can AI diagnose colon polyps on its own?
- AI reads tumor slides to match cancer patients with trials
- Targeted drug combo takes aim at hard-to-treat KRAS-mutant colorectal cancer
- Flushing the right colon Mid-Procedure: a new way to catch hidden polyps?